iShares U.S. Tech Independence Focused ETF (BATS: IETC)

에 대한 최신 뉴스 iShares U.S. Tech Independence Focused ETF (BATS:IETC)

iShares U.S. Tech Independence Focused ETF

Technology

Consumer Cyclical

Communication Services

Financial Services

Industrials

Real Estate

Healthcare

Energy

Consumer Defensive

The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization technology companies. It will hold common stock of those companies that fall into the Technology Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as technology companies. The fund is non-diversified.

Amazon.Com Inc

Broadcom Inc

Microsoft Corp

Nvidia Corp - Common

Salesforce Inc

Accenture Plc

Oracle Corp.

Apple Inc

Alphabet, Inc. (cl A)

Cisco Systems, Inc.

Palantir Technologies Inc.

Verisign Inc.

iShares US Tech Independence Focused ETF

Equities

Large Cap

News

Contracts

IETC

Trust for Professional Managers Jensen Quality Growth ETF

JGRW

NVDA

액센츄어(NYSE:ACN)는 글로벌 기업들이 인공지능(AI) 채택을 빠르게 확장할 수 있도록 지원하기 위해 액센츄어가 새로운 엔비디아 비즈니스 그룹(NVIDIA Business Group)을 설립하는 것을 포함하여 엔비디아(NASDAQ:NVDA)와 확장된 파트너십을 체결했다.

액센츄어와 엔비디아, 글로벌 AI 채택 가속화를 위한 파트너십 체결: 자세한 내용

<a href="https://x.com/JStein_WaPo/status/1917220665821634689" title="https://x.com/JStein_WaPo/status/1917220665821634689">https://x.com/JStein_WaPo/status/1917220665821634689</a>

AMZN

Washington Post Reporter, Jeff Stein, On X Posts "Amazon Spox now saying this was never under consideration for the main Amazon website. Says Amazon Haul has considered listing import price duties on certain products"

UBS analyst Timothy Arcuri maintains Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Buy and lowers the price target from $30 to $22.

Price Target

Analyst Ratings

ALGM

UBS Maintains Buy on Allegro Microsystems, Lowers Price Target to $22

Stephens &amp; Co. analyst Michael Schmidt downgrades SpringWorks Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) from Buy to Neutral and lowers the price target from $77 to $47.

Downgrades

SWTX

Stephens & Co. Downgrades SpringWorks Therapeutics to Neutral, Lowers Price Target to $47

UBS analyst Matheus Enfeldt maintains Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) with a Neutral and lowers the price target from $10.5 to $9.9.

AGRO

UBS Maintains Neutral on Adecoagro, Lowers Price Target to $9.9

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday.
Shares of Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/quote/HON/earnings">raised its FY25 adjusted EPS guidance</a>.
Revenue grew 8% year-over-year (Y/Y, organic: +4% Y/Y) to $9.82 billion, beating the consensus of $9.59 billion. Adjusted EPS was $2.51 (+7% Y/Y), beating the consensus of $2.21.
Honeywell International shares climbed 4.9% to $210.54 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares jumped 23% to $34.99 after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) gained 21.1% to $8.81 after the company reported better-than-expected first-quarter EPS results and raised its FY25 EPS guidance.</li>
<li>Clarivate Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) jumped 16.8% to $4.1950 after the company reported better-than-expected quarterly financial results.</li>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) jumped 16% to $24.90 as the company raised its FY2025 sales guidance.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) gained 15.7% to $22.22 following upbeat quarterly earnings.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) rose 14.8% to $9.19.</li>
<li>ProPetro Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>) shares rose 11.2% to $5.86 after the company reported a first-quarter adjusted EPS and revenue beat.</li>
<li>TriMas Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRS#NYSE">TRS</a>) gained 11.2% to $23.34 following better-than-expected quarterly earnings.</li>
<li>Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) gained 10.4% to $87.96 after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 10.2% to $21.83.</li>
<li>EPWK Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) rose 9.4% to $15.00.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 7% to $96.04 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Noble Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) rose 6.4% to $22.36 after the company reported better-than-expected quarterly sales results.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) gained 5.3% to $156.47 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Intraday Update

Markets

Movers

CECO

CLVT

EPWK

FOUR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

KNSA

LZMH

MTSR

PUMP

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

Piper Sandler analyst Frank Schiraldi maintains Meridian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRBK#NASDAQ">MRBK</a>) with a Neutral and lowers the price target from $17 to $16.

MRBK

Piper Sandler Maintains Neutral on Meridian, Lowers Price Target to $16

UBS analyst Gavin Parsons maintains Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) with a Buy and raises the price target from $200 to $220.

UBS Maintains Buy on Woodward, Raises Price Target to $220

DAAQU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Piper Sandler analyst Nathan Race maintains First Savings Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSFG#NASDAQ">FSFG</a>) with a Overweight and raises the price target from $30 to $32.

FSFG

Piper Sandler Maintains Overweight on First Savings Financial, Raises Price Target to $32

UBS analyst Kevin Caliendo maintains McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) with a Buy and raises the price target from $708 to $805.

UBS Maintains Buy on McKesson, Raises Price Target to $805

Piper Sandler analyst Nathan Race maintains First Northwest Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNWB#NASDAQ">FNWB</a>) with a Neutral and raises the price target from $11.5 to $12.

FNWB

Piper Sandler Maintains Neutral on First Northwest Bancorp, Raises Price Target to $12

UBS analyst Kunal Madhukar maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Neutral and raises the price target from $72 to $73.

EBAY

UBS Maintains Neutral on eBay, Raises Price Target to $73

UBS analyst Kevin Caliendo maintains Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) with a Buy and raises the price target from $298 to $335.

UBS Maintains Buy on Cencora, Raises Price Target to $335

Piper Sandler analyst Luke Lemoine maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Neutral and lowers the price target from $46 to $44.

Piper Sandler Maintains Neutral on Schlumberger, Lowers Price Target to $44

Macro Economic Events

Econ #s

Economics

Dallas Fed Texas Service Sector Index Of General Business Activity Outlook -19.4 In April Vs -11.3 In March

Dallas Fed Texas Service Sector Revenue Index 3.8 In April Vs 1.3 In March

UBS analyst Curt Woodworth maintains Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) with a Buy and raises the price target from $109 to $114.

UBS Maintains Buy on Crown Holdings, Raises Price Target to $114

JetBlue Airways Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) shares slipped Tuesday after posting mixed <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45062405/jetblue-announces-first-quarter-2025-results" rel="noreferrer noopener">first-quarter 2025 results</a>.
The airline reported an adjusted loss of 59 cents per share, narrower than the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">expected 61 cents loss</a> but wider than last year&#8217;s 43 cents loss. Revenue of $2.14 billion was down 3.1% year over year, just missing the $2.15 billion consensus.
In the first quarter of 2025, JetBlue&#8217;s capacity declined 4.3% year over year, while operating expenses fell 21% year over year to $2.3 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/44671680" rel="noreferrer noopener">Which US Airline Faces The Strongest Industry Tailwinds?</a>
Operating revenue per ASM increased by 1.3% YoY, Operating expense per available seat mile (CASM) declined 17.4% YoY, CASM ex-fuel rose 8.3%, and average fuel price was $2.57 per gallon.
JetBlue&#8217;s premium, international, and loyalty segments remain strong under its JetForward strategy. Premium RASM outpaced core RASM, transatlantic RASM rose 28% despite reduced capacity, and loyalty revenue grew 9% year-over-year.
JetBlue ended the quarter with $3.8 billion in liquidity—41% of trailing 12-month revenue, excluding an undrawn $600 million credit facility.
The operating margin for the quarter improved 24.4 points to (8.2)%, and the adjusted operating margin fell to (8.2%) from (7.1)% a year ago.
JetBlue ended the quarter with $2.97 billion in cash and equivalents.
&#8220;In the first quarter we saw booking strength from January deteriorate into February and worsen into March,&#8221; said Marty St. George, JetBlue&#8217;s president.
&#8220;We expect softened demand for off-peak travel to continue into the second quarter, where the booking curve is more exposed to macro uncertainty and deteriorating consumer confidence. That said, we are committed to our JetForward plan and are encouraged by the resiliency of premium, international, and loyalty revenues &#8211; core components of our long-term strategy,&#8221; added Marty.
JetBlue advanced its JetForward strategy in the first quarter with improved reliability, driving a four-point A14 gain and double-digit NPS growth, saving ~0.75 pts in CASM ex-fuel. Northeast BlueCities showed strong margins, while new product perks and a premium co-branded credit card exceeded expectations. Cost initiatives continued, focused on tech efficiencies and fuel optimization.
Guidance Q2: JetBlue anticipates that in the second quarter of 2025, available seat miles (ASM) are expected to decline (3.5%) – (0.5%) year over year. RASM is predicted to be down (7.5%) &#8211; (3.5%) for the second quarter.
CASM ex-fuel is expected to grow 6.5% &#8211; 8.5%, and Fuel Price per Gallon is estimated to be between $2.25 &#8211; $2.40 for the quarter.
JetBlue anticipates a CapEx of $400 million in Q2 and roughly $1.30 billion in 2025
&#8220;As we continue to monitor the evolving macro backdrop, we are evaluating all levers available to us to boost profitability and preserve cash, including additional capacity reductions, targeted cost savings, and further evaluation of our fleet retirement schedule. Given the macroeconomic uncertainty, we are not re-affirming our prior full-year guidance,&#8221; commented Joanna Geraghty, JetBlue&#8217;s chief executive officer.
Price Action: JBLU shares are trading lower by 3.32% at $3.94 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45067312/paypal-earnings-beat-but-slower-spending-and-checkout-use-weigh-on-results" target="_blank" rel="noreferrer noopener">PayPal Earnings Beat, But Slower Spending And Checkout Use Weigh On Results</a></li>
</ul>
Photo by Coby Wayne via Shutterstock

Guidance

JBLU

JetBlue Warns Of Weak Travel Demand, Pulls 2025 Outlook

Stephens &amp; Co. analyst Andrew Terrell reiterates Preferred Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFBC#NASDAQ">PFBC</a>) with a Equal-Weight and maintains $91 price target.

Reiteration

PFBC

Stephens & Co. Reiterates Equal-Weight on Preferred Bank, Maintains $91 Price Target

Piper Sandler analyst Christopher Raymond maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Neutral and lowers the price target from $135 to $115.

BIIB

Piper Sandler Maintains Neutral on Biogen, Lowers Price Target to $115

액센츄어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>)는 글로벌 기업들이 <a href="https://www.benzinga.com/pressreleases/24/10/b41138752/accenture-and-nvidia-lead-enterprises-into-era-of-ai" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">인공지능(AI) 채택을 빠르게 확장</a>할 수 있도록 지원하기 위해 액센츄어가 새로운 엔비디아 비즈니스 그룹(NVIDIA Business Group)을 설립하는 것을 포함하여 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)와 확장된 파트너십을 체결했다.
액센츄어가 엔비디아 비즈니스 그룹은 전 세계 30,000명의 전문가를 교육하여, 고객들이 프로세스를 재구성하고 기업 AI 채택을 AI 에이전트를 사용하여 확장할 수 있도록 지원한다.
액센츄어 AI 리파이너리(Refinery) 플랫폼은 기업들이 전체 엔비디아 AI 스택을 활용하여 맞춤형 AI 여정을 가속화할 수 있도록 도와준다.
액센츄어 AI 리파이너리 엔지니어링 허브(Engineering Hubs)의 네트워크가 유럽, 아시아, 북미에 개설되어, 57,000명의 액센츄어 AI 실무자들이 대규모 운영, 에이전트 아키텍처, 그리고 엔비디아 AI를 활용한 기초 모델 개발을 지원한다.
액센츄어의 마케팅은 AI 리파이너리 플랫폼과 자율 에이전트를 활용하여 캠페인을 간소화하여 수작업 단계를 25-35% 줄이고, 비용을 6% 절감하며, 시장 출시 속도를 25%-55% 증가시킨다.
액센츄어는 가상 시설 로봇 플릿 시뮬레이션을 위한 새로운 엔비디아 님 에이전트 블루프린트(NVIDIA NIM Agent Blueprint)를 출시하여, 산업 기업들이 자율 로봇 운영 공장을 구축할 수 있도록 엔비디아 옴니버스(NVIDIA Omniverse), 아이작(Isaac) 및 메트로폴리스(Metropolis) 소프트웨어를 통합한다.
액센츄어의 회장 겸 CEO인 줄리 스위트(Julie Sweet)는 &#8220;액센츄어 AI 리파이너리는 기업들이 프로세스와 운영을 재구상하고, 새로운 작업 방식을 발견하며, AI 솔루션을 전사적으로 확장하여 지속적인 변화와 가치를 창출할 수 있는 기회를 제공할 것&#8221;이라고 말했다.
엔비디아의 창립자 겸 CEO인 젠슨 황은 &#8220;엔비디아의 플랫폼, 액센츄어의 AI 리파이너리 및 우리의 결합된 전문 지식은 기업과 국가가 이러한 변화를 가속화하여 전례 없는 생산성과 성장을 주도하는 데 도움이 될 것&#8221;이라고 덧붙였다.
투자자들은 Trust For Professional Managers Jensen Quality Growth ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JGRW#NYSE">JGRW</a>)와 IShares U.S. Tech Independence Focused ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/IETC#BATS">IETC</a>)를 통해 주식에 노출될 수 있다.
사진 출처: <a href="https://commons.wikimedia.org/wiki/File:Accenture_Argentina.jpg">Wikimedia Commons</a>
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41069877/accenture-is-a-key-beneficiary-of-genai-analysts-raise-forecasts-after-q4-results" target="_blank" rel="noreferrer noopener">액센츄어는 &#8216;GenAI의 주요 수혜자&#8217;이다: 애널리스트들이 4분기 실적 이후 전망을 상향 조정</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

iShares U.S. Tech Independence Focused ETF

뉴스

에 대한 최신 뉴스 iShares U.S. Tech Independence Focused ETF (BATS:IETC)

수요일, 10월 02, 2024

뉴스

파트너 / 기고자

벤징가 글로벌